Inactivation of the p53 tumour suppressor, either by mutation or by overexpression of its inhibitors Hdm2 and HdmX is the most frequent event in cancer. Reactivation of p53 by targeting Hdm2 and HdmX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback